128 related articles for article (PubMed ID: 23329070)
1. Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities.
Lima MA; Viskov C; Herman F; Gray AL; de Farias EH; Cavalheiro RP; Sassaki GL; Hoppensteadt D; Fareed J; Nader HB
Thromb Haemost; 2013 Mar; 109(3):471-8. PubMed ID: 23329070
[TBL] [Abstract][Full Text] [Related]
2. Generic low-molecular-weight heparins: some practical considerations.
Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
[TBL] [Abstract][Full Text] [Related]
3. A heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activity.
Andrade GP; Lima MA; de Souza Junior AA; Fareed J; Hoppensteadt DA; Santos EA; Chavante SF; Oliveira FW; Rocha HA; Nader HB
Carbohydr Polym; 2013 Apr; 94(1):647-54. PubMed ID: 23544586
[TBL] [Abstract][Full Text] [Related]
4. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521
[TBL] [Abstract][Full Text] [Related]
5. Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA
Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
[TBL] [Abstract][Full Text] [Related]
6. Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.
Xu X; Li D; Chi L; Du X; Bai X; Chi L
Carbohydr Res; 2015 Apr; 407():26-33. PubMed ID: 25701653
[TBL] [Abstract][Full Text] [Related]
7. Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin.
Guerrini M; Elli S; Gaudesi D; Torri G; Casu B; Mourier P; Herman F; Boudier C; Lorenz M; Viskov C
J Med Chem; 2010 Nov; 53(22):8030-40. PubMed ID: 21028827
[TBL] [Abstract][Full Text] [Related]
8. Molecular weight measurements of low molecular weight heparins by gel permeation chromatography.
Mulloy B; Gee C; Wheeler SF; Wait R; Gray E; Barrowcliffe TW
Thromb Haemost; 1997 Apr; 77(4):668-74. PubMed ID: 9134640
[TBL] [Abstract][Full Text] [Related]
9. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin.
Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ
Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427
[TBL] [Abstract][Full Text] [Related]
11. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
[TBL] [Abstract][Full Text] [Related]
12. Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography-mass spectrometry.
Li D; Chi L; Jin L; Xu X; Du X; Ji S; Chi L
Carbohydr Polym; 2014 Jan; 99():339-44. PubMed ID: 24274516
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy.
Guerrini M; Guglieri S; Naggi A; Sasisekharan R; Torri G
Semin Thromb Hemost; 2007 Jul; 33(5):478-87. PubMed ID: 17629844
[TBL] [Abstract][Full Text] [Related]
14. A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety--a review.
Ingle RG; Agarwal AS
Carbohydr Polym; 2014 Jun; 106():148-53. PubMed ID: 24721062
[TBL] [Abstract][Full Text] [Related]
15. Molecular weight of low molecular weight heparins by 13C nuclear magnetic resonance spectroscopy.
Desai UR; Linhardt RJ
Carbohydr Res; 1994 Mar; 255():193-212. PubMed ID: 8181007
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
17. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
18. Heparin and low-molecular-weight heparin.
Gray E; Mulloy B; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
[TBL] [Abstract][Full Text] [Related]
19. Structural elucidation of the tetrasaccharide pool in enoxaparin sodium.
Ozug J; Wudyka S; Gunay NS; Beccati D; Lansing J; Wang J; Capila I; Shriver Z; Kaundinya GV
Anal Bioanal Chem; 2012 Jul; 403(9):2733-44. PubMed ID: 22610547
[TBL] [Abstract][Full Text] [Related]
20. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
